The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma


Cite item

Full Text

Abstract

Despite of the fact that their clinical manifestations are similar, AL-amyloidosis (AL-A) and light chain deposition disease (LCDD) are individual nosological entities in view of considerable differences in their pathogenesis and pathomorphology. The paper describes a rare case of the concurrence of LCDD and AL-A in a patient with multiple myeloma. Clinically, there was dialysis-dependent renal failure, flail leg syndrome, myocardiopathy, and rhabdomyolysis. At the disease onset, his nephrobiopsy specimen could diagnose LCDD and myeloma or cast nephropathy. The disease was characterized by an aggressive course. Despite the administration of innovative agents, the patient had a short-term remission and died from disease progression. Autopsy additionally revealed amyloid deposition in the heart and kidney. The development of AL-A in the presence of prior LCDD may reflect the progression of the tumor and the appearance of an additional subclone of plasma cells that produce amyloidogenic light chains. The uncommonness of this case is that renal amyloid was found in the tubular casts and absent in the glomeruli, which may be considered as a special form – tubular AL-amyloidosis.

References

  1. Dealwis C, Wall J. Towards understanding the structure-function relationship of human amyloid disease. Curr Drug Targets. 2004;5:159-171.
  2. Kaplan B, Ramirez-Alvarado M, Sikkink L, Golderman S, Dispenzieri A, Livneh A, Gallo G. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease. Br J Haematol. 2009;144:705-715. doi: 10.1111/j.1365-2141.2008.07522.x.
  3. Pozzi C, D Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S, Quattrocchio G, Rollino C, Segagni S, Locatelli F. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis. 2003;42(6):1154-1163.
  4. Ronco PM, Alyanakan MA, Mougenot B, Aucouturier P. Light chain deposition disease. A model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol. 2001;12:1558-1565.
  5. Denoroy L, Deret S, Aucouturier P. Overpresentation of V kappa IV subgroup in light chain deposition disease. Immunol Lett. 1994;42:63-66.
  6. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D’Agati VD. Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Society Nephrol. 2001;12:1482-1492.
  7. Khamlichi AA, Rocca A, Touchard G, Aucouturier P, Preud’homme JL, Cogné M. Role of light chain variable region in myeloma with light chain deposition disease: Evidence from an experimental model. Blood. 1995;86:3655-3659.
  8. Deret S, Chomilier J, Huang ,B. Preud’homme JL, Stevens FJ, Aucouturier P. Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. Protein Eng. 1997;10:1191-1197.
  9. Raffen R, Dieckman LJ, Szpunar M, Wunschl C, Pokkuluri PR, Dave P, Wilkins Stevens P, Cai X, Schiffer M, Stevens FJ. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci. 1999;8:509-517.
  10. Santostefano M, Zanchelli F, Zaccaria A, Poletti G, Fusaroli M. The ultrastructural basis of renal patology in monoclonal gammopathies. J Nephrol. 2005;18:659-675.
  11. Рамеев В.В., Козловская Л.В., Жданова Е.А., Гудкова К.В. Кардиоренальные взаимосвязи при системном амилоидозе. Терапевтический архив. 2013;6:51-59.
  12. Buxbaum JN, Chubba JV, Hellman GE, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease. Ann Int Med. 1990;112:455-464.
  13. Nasr SH, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Lacy M, Dispenzieri A, Rajkumar SV, Kyle RA, Leung N.Clinicopathologic correlations in multiple myeloma:a case series of 190 patients with kidney biopsies. Am J Kidney Dis. 2012;59(6):786-794.
  14. Paueksakon P, Revelo M, Horn R, Shappell S, Fogo AB. Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis. 2003;1:87-95.
  15. Herrera GA, Joseph L, Gu X, Hough A, Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004;8:875-879.
  16. Gorchakova SV, Rekhtina IG, Nikitin EA, Birjukova LS. Amino acid sequence of the variable region of light chains in multiple myeloma patients. World Congress of Nephrology. 2009. Abstract 430.
  17. Hutchison CA, Cochwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: In-vitro and in-vivo studies. J Am Soc Nephrol. 2007;18:886-895.
  18. Bridoux F, Fermand JP. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial. Advances In Chronic Kidney Disease. 2012;19:333-341.
  19. Lorenz EC, Sethi S, Poshusta TL, Ramirez-Alvarado M, Kumar S, Lager DJ, Fervenza FC, Leung N. Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant. 2010;25(4):1340-1343.
  20. Keeling J, Teng J, Herrera GA. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Invest. 2004;84:1322-1338.
  21. Teng J, Russel WJ, Gu X, Cardelli J, Jones ML, Herrera GA. Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns. Lab Invest. 2004;84:440-451.
  22. Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light-and heavy-chain deposition diseases. Hematol Oncol Clin Notth Am. 1999;13:1235-1248.
  23. Farah R, Fara R, Kolin M, Cohen H, Kristal B. Light chain muscle deposition caused rhabdomyolysis and acute renal failure in patient with multiple myeloma. Clin Nephrol. 2005;63(1):50-53.
  24. Petrakis I, Stylianou K, Mavroeidi V, Vardaki E, Stratigis S, Stratakis S, Xylouri I, Perakis C, Petraki C, Nakopoulou L, Daphnis E. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation. Nephrol Dial Transplant. 2010;25(6):2020-2023.
  25. Harada K, Akai Y, Sakan H, Yamaguchi Y, Nakatani K, Iwano M, Saito Y. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation. Clin Nephrol. 2010;74(5):384-388.
  26. Sethi S., Hanna MN, Fervenza FC. Unusual casts in a case of multiple myeloma. Am J Kidney Dis. 2009;54:970-974.
  27. Melato M, Falconieri G, Pascali E, Pezzoli A. Amyloid casts within renal tubules: A singular finding in myelomatosis. Virchows Arch A Pathol Anat Histol. 1980;387:133-145.
  28. El-Zoghby Z, Lager D, Gregoire J, Lewin M, Sethi S. Intra-tubular amyloidosis. Kidney Int. 2007; 72:1282-1288.
  29. Friman C, Tornroth T, Wegelius O. IgD myeloma associated with multiple extramedullary amyloid-containing tumors and amyloid casts in the renal tubules. Ann Clin Res. 1970;161-166.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies